Related Experiment Video
Updated: Jul 1, 2026

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest
Published on: May 26, 2023
Sudden cardiac death in pediatrics.
Yaniv Bar-Cohen1, Michael J Silka
1Department of Pediatrics, Division of Cardiology, Childrens Hospital Los Angeles, USC Keck School of Medicine, Los Angeles, California 90027, USA. msilka@chla.usc.edu
Recent advances improve understanding and management of sudden cardiac death (SCD) in children. New strategies enhance risk identification and treatment for pediatric patients facing SCD.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Genetics
- Sudden Cardiac Death Research
Background:
- Sudden cardiac death (SCD) is a critical concern in pediatric populations.
- Understanding the genetic and acquired causes of SCD in children is evolving.
Purpose of the Study:
- To review recent advancements in the understanding of SCD causes in children.
- To highlight improvements in managing pediatric patients at risk for SCD.
Main Methods:
- Literature review of recent studies on pediatric SCD.
- Analysis of progress in genetic cardiovascular diseases and cardiomyopathies.
- Evaluation of updated guidelines for athletic preparticipation screening.
Main Results:
- Enhanced understanding of genetic cardiovascular diseases and their link to SCD.
- Improved management protocols for congenital heart disease patients at risk of SCD.
- Defined strategies for SCD risk reduction in cardiomyopathies and updated screening guidelines.
Conclusions:
- Continued progress in identifying SCD causes and risk factors in children.
- Optimized management strategies including exercise restriction, medication, and device therapy.
- Improved clinical criteria for identifying and managing pediatric SCD risk.
More Related Videos
Related Concept Videos
Introduction Cardiac Emergencies
Cardiopulmonary Resuscitation III: AED Use
Coronary Artery Disease III: Clinical Manifestations
Cardiopulmonary Resuscitation I: Adult
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pharmacokinetics in Pediatric Patients: Drug Excretion

